Traditional Chinese medicine marrow hematogenesis composition and application thereof

Abstract

The invention provides a traditional Chinese medicine marrow hematogenesis composition and an application thereof. The traditional Chinese medicine marrow hematogenesis composition is prepared from the following raw materials in parts by weight: 5-25 parts of human placenta, 5-25 parts of pseudo-ginseng, 15-50 parts of astragalus membranaceus, 10-30 parts of caulis spatholobi, 5-25 parts of radixpseudostellariae, 5-25 parts of glossy privet fruit, 5-25 parts of wolfberry and 5-25 parts of herba epimedii. The marrow hematogenesis composition with a better effect is obtained by combining humanplacenta capable of benefiting qi and nourishing blood, pseudo-ginseng capable of dissipating blood stasis and stopping bleeding, astragalus membranaceus capable of benefiting qi and raising yang, caulis spatholobi capable of promoting salivation and nourishing blood, radix pseudostellariae capable of benefiting qi and invigorating spleen, glossy privet fruit and wolfberry capable of nourishing liver and kidney, and herba epimedii capable of tonifying kidney yang. The traditional Chinese medicine marrow hematogenesis composition provided by the invention has the advantages that the symptom ofleucopenia of tumor patients after chemotherapy is very effectively improved, and the marrow suppression after chemotherapy is improved.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine compositions, more specifically, to a traditional Chinese medicine bone marrow hematopoietic composition and its application. Background technique [0002] Malignant tumors are serious diseases that threaten human survival and health. In recent years, with the intensification of environmental pollution and the increase of work and employment pressure, the prevalence of malignant tumors in my country has increased year by year, and it has become an important disease of human health after cardiovascular and cerebrovascular diseases. Drug chemotherapy is one of the main methods to treat malignant tumors. However, due to the toxicity of drugs, leukopenia can occur after most chemotherapy, which will bring great pain to patients and seriously affect the compliance of patients, and even further affect the implementation of the treatment plan. Subcutaneous injection of recombinant human gran...

AI Technical Summary

Problems solved by technology

[0003] Leukopenia is mostly secondary to the treatment of chemical drugs in the course of anti-malignant tumor treatment, which can lead to a decrease in the quality of life of patients, and the risk of various complications, which has adverse effects on the body, and requires timely and effective treatment

For the treatment of secondary leukopenia, various drugs such as Diyushengbaipian and recombinant human granulocyte colony-stimulating factor are used to stimulate hematopoiesis and increase granulocytes, but the effect is not good

Traditional Chinese medicine uses various bone marrow Shengxue pills for treatment, but the effect is not very satisfactory

Images